Takeda Pharmaceutical
TAK
#419
Rank
โ‚น5.366 T
Marketcap
โ‚น1,699
Share price
0.00%
Change (1 day)
43.02%
Change (1 year)

Revenue for Takeda Pharmaceutical (TAK)

Revenue in 2025 (TTM): โ‚น2.612 Trillion

According to Takeda Pharmaceutical's latest financial reports the company's current revenue (TTM ) is โ‚น2.718 Trillion. an increase over the revenue in the year 2024 that were of โ‚น2.566 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Takeda Pharmaceutical from 2009 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น2.680 T4.44%
2024 โ‚น2.566 T5.01%
2023 โ‚น2.444 T-0.33%
2022 โ‚น2.452 T6.58%
2021 โ‚น2.300 T4.18%
2020 โ‚น2.208 T4.3%
2019 โ‚น2.117 T87.55%
2018 โ‚น1.129 T11.12%
2017 โ‚น1.015 T-6.43%
2016 โ‚น1.085 T7.67%
2015 โ‚น1.008 T-1.08%
2014 โ‚น1.019 T-0.9%
2013 โ‚น1.028 T-2.42%
2012 โ‚น1.054 T7.82%
2011 โ‚น977.71 B32.59%
2010 โ‚น737.39 B2.28%
2009 โ‚น720.92 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚น8.389 T 208.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น5.159 T 89.79%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น5.716 T 110.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น3.274 T 20.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น4.326 T 59.16%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น5.848 T 115.12%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น3.855 T 41.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
โ‚น209.42 B-92.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
โ‚น360.10 B-86.75%๐Ÿ‡ฎ๐Ÿ‡ณ India